nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice
|
Alsakini, Karrar Ali Mohammed Hasan |
|
|
85 |
C |
p. |
artikel |
2 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
|
85 |
C |
p. |
artikel |
3 |
An antibody-free evaluation of an mRNA COVID-19 vaccine
|
Branham, Paul J. |
|
|
85 |
C |
p. |
artikel |
4 |
A rapid and simple sterility test method based on solid culture medium containing blood
|
Raghav, Neetu |
|
|
85 |
C |
p. |
artikel |
5 |
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency
|
Mirhassani, Reihaneh |
|
|
85 |
C |
p. |
artikel |
6 |
Development of an ELISA for the detection of fowl adenovirus serotype −4 utilizing fiber protein
|
Ather, Faiza |
|
|
85 |
C |
p. |
artikel |
7 |
Efficient extraction of adventitious virus nucleic acid using commercially available methods
|
Valiant, William G. |
|
|
85 |
C |
p. |
artikel |
8 |
Enabling the evaluation of COVID-19 vaccines with correlates of protection
|
Marchant, Arnaud |
|
|
85 |
C |
p. |
artikel |
9 |
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report
|
Jamrozik, Euzebiusz |
|
|
85 |
C |
p. |
artikel |
10 |
Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products
|
Hirai, Takamasa |
|
|
85 |
C |
p. |
artikel |
11 |
Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections
|
El-Mowafy, Mohammed |
|
|
85 |
C |
p. |
artikel |
12 |
Fifty years of advancing biologicals and beyond
|
Gupta, Rajesh |
|
|
85 |
C |
p. |
artikel |
13 |
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
|
Cavaleri, Marco |
|
|
85 |
C |
p. |
artikel |
14 |
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023
|
Kapulu, Melissa |
|
|
85 |
C |
p. |
artikel |
15 |
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools
|
Köseoğlu, Ahmet Efe |
|
|
85 |
C |
p. |
artikel |
16 |
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics
|
Samananda Singh, Loushambam |
|
|
85 |
C |
p. |
artikel |
17 |
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis
|
Silvarrey, Cecilia |
|
|
85 |
C |
p. |
artikel |
18 |
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology
|
Monterrubio-López, Gloria Paulina |
|
|
85 |
C |
p. |
artikel |
19 |
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report
|
Corti, Nicoletta |
|
|
85 |
C |
p. |
artikel |
20 |
Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation
|
Choi, Chan Woong |
|
|
85 |
C |
p. |
artikel |
21 |
The current status of the biosimilars landscape in China
|
Xu, Gangling |
|
|
85 |
C |
p. |
artikel |
22 |
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report
|
Bollaerts, Kaatje |
|
|
85 |
C |
p. |
artikel |
23 |
Viral clearance capability of monoclonal antibody purification
|
Cai, Kang |
|
|
85 |
C |
p. |
artikel |